Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.
Haque
T
T
Department of Medical Microbiology, University of Edinburgh Medical School, UK.
Crawford
D H
DH
D000818:Animals; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004279:DNA, Viral / Q000032:analysis; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D016679:Genome, Viral; D004854:Herpesvirus 4, Human; D006801:Humans; D007167:Immunotherapy / Q000639:trends; D008232:Lymphoproliferative Disorders / Q000150:complications / Q000628:therapy / Q000821:virology*; D016377:Organ Transplantation / Q000009:adverse effects*; D016133:Polymerase Chain Reaction; D012307:Risk Factors; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D004279:DNA, Viral